Dosage regimen of an S1P receptor agonist

Details for Australian Patent Application No. 2009331582 (hide)

Owner Novartis AG

Inventors Legangneux, Eric

Agent Davies Collison Cave

Pub. Number AU-A-2009331582

PCT Pub. Number WO2010/072703

Priority 09167209.7 04.08.09 EP; 61/139,673 22.12.08 US

Filing date 21 December 2009

Wipo publication date 1 July 2010

International Classifications

A61K 31/192 (2006.01)

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/401 (2006.01) - Proline

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/072703 Priority application(s): WO2010/072703

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009331596-Method for detecting an electric arc in photovoltaic equipment

2009331581-Drug delivery device with piston rod carrying dose markings